Pfizer Inc said on Wednesday it will provide an additional 2.5 million doses of its COVID-19 pill Paxlovid to the United Kingdom, Trend reports with reference to Reuters.
A total of 2.75 million doses of the pill are expected to be delivered to the UK through 2022, the drugmaker said.